Canaloplasty is a stent-free, minimally invasive glaucoma surgery that works with patient physiology to reduce intraocular pressure in glaucoma patients.
Kern has 20 years of experience leading product optimization, supporting regulatory approvals, and establishing cGMP compliant manufacturing solutions.
New board member will serve as a visionary for the company as it moves forward with new innovations in medical data, artificial intelligence, and telemedicine.
Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.